Skip to main content

Advertisement

Figure 1 | Arthritis Research & Therapy

Figure 1

From: Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus

Figure 1

Influence of an induction therapy with mycophenolate mofetil (MMF) or cyclophosphamide (CYC) on plasmablast and plasma cell counts. CD27++CD38++HLADRhigh plasmablast (A) and CD27++CD38++HLADRlow plasma cell counts (C) prior to and approximately 16 and 31 weeks after start of induction therapy with MMF. CD27++CD38++HLADRhigh plasmablast (B) and CD27++CD38++HLADRlow plasma cell counts (D) prior to and approximately 15 weeks after start of induction therapy with CYC. Statistical analyses were performed using the Wilcoxon’s matched pairs signed rank test and P-values <0.05 were considered significant.

Back to article page